Detalhe da pesquisa
1.
GADECCU 2022 Guideline for the treatment of Ulcerative Colitis. Adaptation and updating of the GETECCU 2020 Guideline. / Guía GADECCU 2022 para el tratamiento de la colitis ulcerosa. Adaptación y actualización de la Guía GETECCU 2020.
Gastroenterol Hepatol
; 46 Suppl 1: S1-S56, 2023 Mar.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-36731724
2.
GETECCU 2020 guidelines for the treatment of ulcerative colitis. Developed using the GRADE approach. / Guía GETECCU 2020 para el tratamiento de la colitis ulcerosa. Elaborada con metodología GRADE.
Gastroenterol Hepatol
; 43 Suppl 1: 1-57, 2020 Aug.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-32807301
3.
Recommendations of the Crohn's Disease and Ulcerative Colitis Spanish Working Group (GETECCU) for the treatment of perianal fistulas of Crohn's disease. / Recomendaciones del Grupo Español de Trabajo de Enfermedad de Crohn y Colitis Ulcerosa (GETECCU) para el tratamiento de las fístulas perianales de la enfermedad de Crohn.
Gastroenterol Hepatol
; 43(3): 155-168, 2020 Mar.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-31870681
4.
Relationship between Serum Adalimumab Levels and Clinical Outcome in the Treatment of Inflammatory Bowel Disease.
Dig Dis
; 37(6): 444-450, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31039560
5.
Fecal Calprotectin Pretreatment and Induction Infliximab Levels for Prediction of Primary Nonresponse to Infliximab Therapy in Crohn's Disease.
Dig Dis
; 37(2): 108-115, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30149385
6.
Validation of a population pharmacokinetic model of adalimumab in a cohort of patients with inflammatory bowel disease.
Rev Esp Enferm Dig
; 111(6): 431-436, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-31021170
7.
Vedolizumab, an option in patients with inflammatory bowel disease intolerant to thiopurines and refractory to biological agents. / Vedolizumab, una opción en pacientes con enfermedad inflamatoria intestinal intolerantes a tiopurinas y refractarios a biológicos.
Gastroenterol Hepatol
; 41(9): 535-543, 2018 Nov.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-30031573
8.
Pharmaceutical costs for inflammatory bowel disease units - An issue for department heads? The GESTIONAEII survey.
Rev Esp Enferm Dig
; 108(6): 380-1, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-26937746
9.
How is inflammatory bowel disease managed in Spanish gastroenterology departments? The results of the GESTIONA-EII survey.
Rev Esp Enferm Dig
; 108(10): 618-626, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-27651018
10.
Information resources used by patients with inflammatory bowel disease: Satisfaction, expectations and information gaps.
Gastroenterol Hepatol
; 38(6): 355-63, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25813702
11.
Joint position statement by "Sociedad Española de Patología Digestiva" (Spanish Society of Gastroenterology) and "Sociedad Española de Farmacología" (Spanish Society of Pharmacology) on biosimilar therapy for inflammatory bowel disease.
Rev Esp Enferm Dig
; 105(1): 37-43, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23548008
12.
Therapeutic guidelines on ulcerative colitis: a GRADE methodology based effort of GETECCU.
Gastroenterol Hepatol
; 36(2): 104-14, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23332546
13.
[Peripheral arterial thromboembolism in Crohn's disease]. / Tromboembolia arterial periférica en enfermedad de Crohn.
Gastroenterol Hepatol
; 36(1): 30-4, 2013 Jan.
Artigo
em Espanhol
| MEDLINE | ID: mdl-22749513
14.
Evaluation of AIF-1 (Allograft Inflammatory Factor-1) as a Biomarker of Crohn's Disease Severity.
Biomedicines
; 10(3)2022 Mar 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35327530
15.
Risk of Immunomediated Adverse Events and Loss of Response to Infliximab in Elderly Patients with Inflammatory Bowel Disease: A Cohort Study of the ENEIDA Registry.
J Crohns Colitis
; 16(6): 946-953, 2022 Jul 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34864947
16.
A new guidewire cannulation technique in ERCP: successful deep biliary access with triple-lumen sphincterotome and guidewire controlled by the endoscopist.
Surg Endosc
; 25(6): 1876-82, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21136105
17.
Clinical outcome after anti-tumour necrosis factor therapy discontinuation in 1000 patients with inflammatory bowel disease: the EVODIS long-term study.
Aliment Pharmacol Ther
; 53(12): 1277-1288, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33962482
18.
Relationship between IGF-1 and body weight in inflammatory bowel diseases: Cellular and molecular mechanisms involved.
Biomed Pharmacother
; 144: 112239, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34601192
19.
Effectiveness and Safety of Ustekinumab in Ulcerative Colitis: Real-world Evidence from the ENEIDA Registry.
J Crohns Colitis
; 15(11): 1846-1851, 2021 Nov 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33860795
20.
Survey on the use of capsule endoscopy for patients with known or suspected Crohn's disease in Spain.
Rev Esp Enferm Dig
; 107(7): 463-4, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-26140650